{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-022814","form_type":"8-K","ticker":"MBOT","cik":"0000883975","company_name":"Microbot Medical Inc.","filed_at":"2023-06-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.596512+00:00","generated_at":"2026-06-13T15:13:53.697936+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Microbot Medical raises $2M in registered direct offering; aggregate $7.6M from four offerings","bullets":["Issued 624,618 shares of common stock at $3.25 per share in registered direct offering.","Concurrent private placement of Series D warrants to purchase up to 312,309 shares at $3.19/share, exercisable for 5.5 years.","Gross proceeds from this offering ~$2.0M; total from four recent closings ~$7.6M.","Net proceeds to fund development of LIBERTY Robotic System, IP expansion, and working capital.","H.C. Wainwright & Co. served as exclusive placement agent, receiving 7% cash fee and warrants."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-022814","json":"https://secwatch.observer/filing/0001493152-23-022814.json","markdown":"https://secwatch.observer/filing/0001493152-23-022814.md","text":"https://secwatch.observer/filing/0001493152-23-022814.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883975/000149315223022814/0001493152-23-022814-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883975/000149315223022814/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T15:13:53.697936+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"068ab88be08e7f21d8f798dd9614ee65f354180a","claim":"Microbot Medical Inc. entered into Securities Purchase Agreements with institutional investors valued at aggregate gross proceeds from the Offerings ... of approximately $2.0 million (effective 2023-06-26).","evidence_excerpt":"On June 26, 2023, Microbot Medical Inc., a Delaware corporation (the “Company”), entered into Securities Purchase Agreements (the “Purchase Agreements”) with institutional investors (the “Investors”), pursuant to which the Company agreed to issue and sell, in a registered direct offering priced at-the-market under the rules of The Nasdaq Stock Market (the “Registered Offering”), an aggregate of 624,618 shares (the “Shares”) of the Company’s common stock, par value $0.01 per share (“Common Stock”), at an offering price of $3.25 per share, for aggregate gross proceeds from the Offerings (as defined below) of approximately $2.0 million before deducting the placement agent fee (as described in greater detail below) and related offering expenses.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/883975/000149315223022814/0001493152-23-022814-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"institutional investors"},{"label":"Value","value":"aggregate gross proceeds from the Offerings ... of approximately $2.0 million"},{"label":"Effective","value":"2023-06-26"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}